Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide - Praga, C; Bergh, J; Bliss, J (J Clin Oncol, 2005)
et al.